HISTORY
Footsteps of L&C BIO
2025
~
2021
Towards the world
beyond Korea
2025 ~ 2023
Towards the world beyond Korea
2025 ~ 2023
MegaDerm® Plus obtained product license from China’s NMPA
Launched Elravie Re2O
Accredited by the American Association of Tissue Banks (AATB)
Selected as a KOSDAQ Rising-Star in 2024
L&C China obtains permission to import human tissue into China
Established subsidiary – L&C FutureLab Co., Ltd.
Launched MegaNerve Prime®(Decellularized Nerve Allograft)
Launched MegaCarti
2022 ~ 2021
Established a labor’s welfare fund in the company
Established R&D Center - L&C ES Co., Ltd.
Selected as a KOSDAQ Rising-Star in 2023
Established a subsidiary – L&C Medicare Co., Ltd.
Completed construction of China(Kunshan) manufacturing facility
Obtained NDA certification for MegaCarti®(The world's first human tissue-based hyaline cartilage reconstruction medical device)
Launched MegaDerm® Star
2020~2018
Entering into a new market
2020 ~ 2018
Obtained Hainan FDA approval(MegaDerm® Plus)
Selected as a KOSDAQ Rising-Star in 2021
Established a subsidiary – L&C ES Co., Ltd.
Acquired a GMP-certified facility for Medical Device
Obtained the first three medical field certifications/licenses domestically - GTP for Human tissue process in industry/GMP for Medical Device/GMP for Pharmaceuticals
Obtained KGMP for Pharmaceutical
Selected as a KOSDAQ Rising-Star in 2020
Established a subsidiary – L&C Bio Science Technology Co.,LTD(L&C China)
Expansion and relocation of Human Tissue (Medical Device) Production Plants 1 and 2 (Seongnam, Gyeonggi-do)
Established a Pharmaceutical manufacturing facility
Obtained additional GMP certification for Medical supplies for external body part
2017~2015
Laying the foundation for advancement
2017 ~ 2015
Listed on KOSDAQ in 2018
Signed the domestic distribution agreement for Fluobeam®
Establishment of L&C BIO Office in Seoul (Dosan-daero, Gangnam-Gu, Seoul)
Established a subsidiary – Global Medical Research Center (Cosmetic Clinical Trials, New Substance Development)
Presidential Commendation for Contribution to Job Creation
Ministerial Commendation from the Ministry of Trade, Industry, and Energy
Commendation from the Minister of Employment and Labor
Selected as a Youth-Friendly Small and Medium-sized Enterprise (Ministry of Employment and Labor)
Selected as the foreign private network(KOSME)
Selected as Gyeonggi's Best Employer of Women's employment (Gyeonggi Province)
Obtained ISO 13485 and GMP
Selected as a High Growth Company with Technology Innovation (Ministry of SMEs and Startups)
2014~2013
Creating the basis for growth
2014 ~ 2013
Selected as a High Growth Company (KOSME)
Selected as the excellent domestic demand enterprise for export(KOTRA)
Technology Transfer and Joint Research Agreement on 'Skin Disease Treatment' with Yonsei Medical Center
Selection as an Excellent Employer of employment (Seongnam)
Chosen for INNO-BIZ(Small and medium companies in Technical Innovation) (Ministry of SMEs and Startups)
Certification as a Small and Medium-sized Enterprise for Human Resources Development (Ministry of SMEs and Startups)
Gyeonggi Province Small and Medium-sized Enterprise Growth and Development Commendation (Gyeonggi Province)
Selected as the top promising small and medium companies in Gyeonggi-do
Started Medical device business
Designated as an Exempted Military Service Company (Military Manpower Administration)
Started Cosmetics business
2012~2011
Start new challenges
2012 ~ 2011
Selected as an IP Star Company (KIPO)
Selected as a G-STAR company in Gyeonggi-do
Selected as the top promising Small and Medium-sized Enterprise in export (SMBA)
Selected as a Leading Company(KOSME)
Completed the 2nd processing facility
Obtained ISO 9001/14001 certifications
Obtained Venture Company (KIBO)
Established an R&D Center
Started Human Tissue business (Skin and Cartilage)
Completion of the First Factory Construction and Approval for establishing human tissue bank
Established L&C BIO Inc.